 |
|
|
|
|
|
|
|
|
|
|
|
1 to 10 of 10 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Cirrito J. on NEWS: Endocytosis Pulls α-Secretase From Synapses, Marcello and colleagues demonstrate that synaptic activity regulates the levels of ADAM10 on the... 13 May 2013.
|
|
|
 |
|
|
Cirrito J. on PAPER: Iliff JJ. et al., 2012, Iliff and colleagues use a clever approach to describe a brand-new bulk flow clearance pathway... 17 Aug 2012.
|
|
|
|
|
|
Cirrito J. on PAPER: Brouillette J. et al., 2012, Brouillette and colleagues have developed a system where they can inject synthetic Aβ... 9 Jun 2012.
|
|
|
|
|
|
Cirrito J. on NEWS: Research Brief: Robots Trained in Patch-Clamp Experiments, Whole-cell patch-clamp has been a mainstay neuroscience tool for decades, but is generally only... 15 May 2012.
|
|
|
|
|
|
Cirrito J. on PAPER: Wu J. et al., 2011, This is an interesting study by Wu and colleagues. Arc appears to mediate PS1 trafficking... 1 Nov 2011.
|
|
|
|
|
|
Cirrito J. on PAPER: Krohn M. et al., 2011, Dr. Krohn and colleagues have identified another Aβ transporter at the CNS-blood barrier, ABCC1.... 19 Sep 2011.
|
|
|
|
|
|
Cirrito J. on PAPER: Restituito S. et al., 2011, Restituito and colleagues provide interesting and compelling evidence that α-secretase/matrix... 27 Aug 2011.
|
|
|
|
|
|
Cirrito J. on PAPER: Tampellini D. et al., 2009, This paper by Tampellini and colleagues is an interesting account of amyloid precursor protein... 12 Aug 2009.
|
|
|
|
|
|
Cirrito J. on PAPER: Rissman RA. et al., 2007, Stress exacerbates many, if not most, diseases. That stress appears to play a role in Alzheimer... 22 Jun 2007.
|
|
|
|
|
|
Cirrito J. on PAPER: Ting JT. et al., 2007, Ting et al. provide an interesting and well-done analysis of how endogenous Abeta may depress... 5 Jan 2007.
|
|
|
|
|
|
|
1 to 10 of 10 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
